Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000427

Drug Information
NameZopiclone    
SynonymsZopiclon-TEVA; Zopiclon beta; Lopac0_001270; C515050; Bio-0528; Biomol-NT_000284; Zopiclon AZU; Zopiclon AbZ; Azupharma brand of zopiclone; Zopitan; Siaten; NCGC00024993-03; 6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate; Rhodiapharm brand of zopiclone; Aliud brand of zopiclone; Pinewood brand of zopiclone; Zopiclona [INN-Spanish]; Hormosan brand of zopiclone; RP 27267; CHEBI:324263; Opus brand of zopiclone; AC1L1L0T; Zopiclon TAD; 27267 R.P; Zileze; 138680-07-6; 6-(5-chloropyrid-2-yl)-5-(4-methylpiperazin-1-yl)carbonyloxy-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine; Limovan; Rhone-Poulenc Rorer brand of zopiclone; Amoban; D01372; Stadapharm brand of zopiclone; Zopiclone [BAN:INN:JAN]; Z 4900; Temmler brand of zopiclone; Zimoclone; C17H17ClN6O3; Zopiclonum [INN-Latin]; Zopiclon AL; Amoban (TN); Zopiclone (JAN/INN); 4-Methyl-1-piperazinecarboxylic acid 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester; zopiclodura; Italfarmaco brand of zopiclone; Clonmel brand of zopiclone; Ran-zopiclone; BRD-A34309505-001-08-5; Hexal brand of zopiclone; Gerard brand of zopiclone; Optidorm; Rhovane; S1446_Selleck; Norton brand of zopiclone; 1-Piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl ester; Zopiclonum; Ratiopharm brand of zopiclone; Imovance; ratio-Zopiclone; ct-Arzneimittel brand of zopiclone; DB01198; STK599439; Nu-Pharm brand of zopiclone; Zopiclona; MLS001201837; Zopiclon-neuraxpharm; Dolorgeit brand of zopiclone; zopiclon von ct; Zorclone; EU-0101270; (+-)-Zopiclone; MLS001304058; AbZ brand of zopiclone; BPBio1_001146; Ciclum brand of zopiclone; Aventis brand of zopiclone; Amovane; Zopi-Puren; Zopiclon Stada; CID5735; 43200-80-2; RP 27 267; 4-Methyl-1-piperazinecarboxylic acid ester with 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5H-pyrrolo(3,4-b)pyrazin-5-one; MLS000083579; 6-(5-Chloro-2-pyridinyl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methyl-1-piperazinecarboxylate; MolPort-002-507-850; Z4900_SIGMA; Novo-zopiclone; NCGC00024993-04; neuraxpharm brand of zopiclone; Zopicalm; Merck dura brand of zopiclone; CHEBI:32315; Imovane; 1-Piperazinecarboxylic acid, 4-methyl-, 6-(5-chloro-2-pyridinyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4-b]pyrazin-5-yl ester; 6-(5-chloro-2-pyridyl)-6,7-dihydro- 7-oxo-5H-pyrrolo(3,4-b)pyrazin-5-yl 4-methyl-1- piperazinecarboxylate; betapharm brand of zopiclone; Ximovan; CHEMBL135400; BRN 0768704; Zopiclone (TN); Sopivan; Aventis Pharma brand of zopiclone; TAD brand of zopiclone; UNII-03A5ORL08Q; Zopicalma; EINECS 256-138-9; Alpharma brand of zopiclone; 27267 R.P.; Zopiclon-ratiopharm; Zimovane; SMR000048685; LS-110937; [6-(5-chloropyridin-2-yl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate; nchembio747-comp16; MLS000028547; Teva brand of zopiclone; RP-27267; Nu-Zopiclone; zopiclone; Zopiclone, Imovane, Zimovane, Lunesta    
Trade NameImovane; Zimovane; Lunesta; Zopinox    
CompanySanofi-Aventis    
IndicationInsomniaApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassHypnotics and Sedatives    
CAS NumberCAS 43200-80-2
FormularC17H17ClN6O3    
PubChem Compound IDCID 5735.    
PubChem Substance IDSID 180420.    
SuperDrug ATC IDN05CF01;    
SuperDrug CAS ID043200802;    
TargetGamma-aminobutyric acid A receptorBinder[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021476 To Reference
Ref 2Eszopiclone: its use in the treatment of insomnia. Neuropsychiatr Dis Treat. 2007 Aug;3(4):441-453. To Reference
Ref 3The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents. CNS Drugs. 2004;18 Suppl 1:9-15; discussion 41, 43-5. To Reference
Ref 4Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543